WHO approves AstraZeneca coronavirus vaccine for emergency use

• The decision widens the developing world’s access to the relatively inexpensive jab, though production still needs to be scaled up
• The World Health Organization review found that AstraZeneca’s jab met the ‘must-have’ criteria for safety, and its efficacy benefits outweighed its risks